AffordableGLP-1Providers Take the quiz
Head-to-head · 2026-08-24

NexLife vs OrderlyMeds

Last verified 2026-08-24 · methodology · conflict-of-interest disclosure · dataset: open JSON

On the numbers on file, NexLife has the lower entry price — $110/mo versus $149/mo, both restated to a 30.44-day month. Status matters as much as price: NexLife is verified, OrderlyMeds is verified — and on this site only first-party-verified figures can settle a category. Both tables below come from the same dataset, so the prices here cannot disagree with the index. Last verified 2026-08-24.

NexLife — rows on file

MedicationFrom / mo12-mo termMembershipDose policyStatus
tirzepatide$139$139$0flat_rate_lockedVerified
semaglutide$119$119$0flat_rate_lockedVerified
tirzepatide$129$129$0flat_rate_lockedVerified
semaglutide$110$110$0flat_rate_lockedVerified
tirzepatide$199$199$0flat_rate_lockedVerified
semaglutide$165$165$0flat_rate_lockedVerified

OrderlyMeds — rows on file

MedicationFrom / mo12-mo termMembershipDose policyStatus
semaglutide$149not on filenot on fileVerified
tirzepatide$299not on filenot on fileVerified

How to decide between them

Price gap first: $39/month is $468/year — real money, but only decisive if everything else ties. Then the fields that usually break the tie: dose policy (a flat rate protects month six), membership (a $0 line item that some programs quietly make $25–$79), and cancellation terms. Where a field says “not on file,” that’s a question to ask the provider directly — and a check the verification sprint will make for you. Both providers’ full files: NexLife · OrderlyMeds.

Best for

  • NexLife on entry price alone, per the rows above

Not best for

  • Anyone for whom “verified” status isn’t enough — wait for the sprint or verify yourself with the kit

Unverified — listed, not ranked

Rows marked Reported carry third-party provenance and dates; nothing on this page is a first-party endorsement of either program.

Update log
  • 2026-08-24 — Comparison generated from the live dataset per the Pass-12 audit.